CSN4基因干扰对乳腺癌MDA-MB-231细胞增殖和凋亡的影响

doi:10.16288/j.yczz.18-278

遗传 ›› 2019, Vol. 41 ›› Issue (4): 318-326.doi: 10.16288/j.yczz.18-278

CSN4基因干扰对乳腺癌MDA-MB-231细胞增殖和凋亡的影响

余同露^1,²,蔡栋梁^1,²,朱根凤^1,²,叶晓娟^1,²,闵太善^1,²,陈红岩^1,²,卢大儒^1,²,陈浩明^1,²()

^1. 复旦大学生命科学学院,上海 200438
^2. 复旦大学现代人类学教育部重点实验室,上海 200438

收稿日期:2018-12-11 修回日期:2019-02-18 出版日期:2019-04-20 发布日期:2019-03-15
通讯作者: 陈浩明 E-mail:hmchen@fudan.edu.cn
作者简介:余同露,硕士研究生;专业方向：生物工程。E-mail: 15210700122@fudan.edu.cn
基金资助:
国家自然科学基金项目(81071739);国家自然科学基金项目(81272385)

Effects of CSN4 knockdown on proliferation and apoptosis of breast cancer MDA-MB-231 cells

YU Tonglu^1,²,Cai Dongliang^1,²,Zhu Genfeng^1,²,Ye Xiaojuan^1,²,Min Taishan^1,²,Chen Hongyan^1,²,Lu Daru^1,²,Chen Haoming^1,²()

^1. School of Life Sciences, Fudan University, Shanghai 200438, China
^2. MOE Key Laboratory of Contemporary Anthropology, Fudan University, Shanghai 200438, China

Received:2018-12-11 Revised:2019-02-18 Online:2019-04-20 Published:2019-03-15
Contact: Chen Haoming E-mail:hmchen@fudan.edu.cn
Supported by:
the National Natural Science Foundation of China(81071739);the National Natural Science Foundation of China(81272385)

摘要/Abstract

摘要：

乳腺癌目前是危害女性常见的恶性肿瘤,研究发现COP9复合体中的各个亚基与恶性肿瘤的发生发展密切相关,且CSN4亚基对整个复合体具有很重要的调节作用。为探讨CSN4基因在乳腺癌细胞中的生物学功能及其分子作用机制,本研究首先在乳腺癌细胞MDA-MB-231中,成功建立了慢病毒介导的CSN4基因的干扰表达体系,并通过细胞表型实验、CCK8实验和细胞克隆形成实验证实CSN4基因表达的干扰能显著抑制乳腺癌MDA-MB-231细胞的增殖速率和克隆形成能力。流式细胞检测结果表明,干扰CSN4的表达能显著增加Sub G₁期乳腺癌MDA-MB-231细胞比例;凋亡检测结果表明,干扰CSN4的表达能显著增加早期凋亡和晚期凋亡细胞的比例,这证明干扰CSN4的表达能够促进乳腺癌细胞凋亡。最后,通过Western blot实验证实CSN4能调控CDK6和Caspase3蛋白的表达,激活Caspase3切割PARP,揭示CSN4可调控CDK6和Caspase3 的表达从而影响乳腺癌细胞的增殖和凋亡。本研究结果进一步加深了人们对乳腺癌细胞凋亡和细胞生长的分子机制的认识,同时也进一步揭示了CSN4在肿瘤生物学中的作用和机制。

关键词: 乳腺癌, CSN4, 细胞增殖, 细胞凋亡, CDK6, Caspase3

Abstract:

Breast cancer is one of the most common malignant tumors endangering women. It has been found that the subunits of the COP9 complex are closely related to the occurrence and development of malignant tumors, and the CSN4 subunit plays an important role in regulating the whole complex. In the breast cancer cell line MDA-MB-231, we successfully established a lentivirus-mediated CSN4-knockdown cell line. CCK8 cell proliferation assays and colony formation experiments confirmed that CSN4 knockdown significantly decreased the cellular proliferation rate. Cell cycle analysis showed that CSN4 knockdown increased sub-G1 population and induced apoptosis. In addition, Western blotting assays confirmed that CSN4 regulates the expression of CDK6 and Caspase3, suggesting that CSN4 modulates the proliferation and apoptosis of breast cancer cells by regulating the expression of CDK6 and Caspase3 genes and thereby tumorigenesis. This study has deepened our understanding of the molecular mechanism of apoptosis and cell growth in breast cancers, and further revealed the role and mechanism of CSN4 in cancer biology.

Key words: breast cancer, CSN4, cell proliferation, cell apoptosis, CDK6, Caspase3

余同露,蔡栋梁,朱根凤,叶晓娟,闵太善,陈红岩,卢大儒,陈浩明. CSN4基因干扰对乳腺癌MDA-MB-231细胞增殖和凋亡的影响[J]. 遗传, 2019, 41(4): 318-326.

YU Tonglu,Cai Dongliang,Zhu Genfeng,Ye Xiaojuan,Min Taishan,Chen Hongyan,Lu Daru,Chen Haoming. Effects of CSN4 knockdown on proliferation and apoptosis of breast cancer MDA-MB-231 cells[J]. Hereditas(Beijing), 2019, 41(4): 318-326.

参考文献

[1]	Bhoi AK, Das SK, Majhi D, Sahu PK, Nijamudheen A, N A, Rahaman A, Sarkar M . Analyte interactions with a new ditopic dansylamide-nitrobenzoxadiazole dyad: a combined photophysical, NMR, and theoretical (DFT) study. J Phys Chem B, 2014,118(33):9926-9937.
[2]	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J . Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians, 2016,66(2):115-132.
[3]	Corbex M, Bouzbid S, Traverse-Glehen A, Aouras H, McKay-Chopin S, Carreira C, Lankar A, Tommasino A, Gheit T . Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors. PLoS One, 2014,9(12):e114559.
[4]	Maytal-Kivity V, Pick E, Piran R, Hofmann K, Glickman MH . The COP9 signalosome-like complex in S. cerevisiae and links to other PCI complexes. Int J Biochem Cell Biol, 2003,35(5):706-715.
[5]	Rajan KE, Rajkumar R, Liao CC, Ganesh A, Marimuthu G . Light-induced COP9 signalosome expression in the Indian false vampire bat Megaderma lyra. J Physiol Sci, 2010,60(1):43-49.
[6]	Dubiel D, Rockel B, Naumann M, Dubiel W . Diversity of COP9 signalosome structures and functional consequences. FEBS Lett, 2015,589(19 Pt A):2507-2513.
[7]	Lingaraju GM, Bunker RD, Cavadini S, Hess D, Hassiepen U, Renayus M, Fischer ES, Thomä NH . Crystal structure of the human COP9 signalosome. Nature, 2014,512(7513):161-165.
[8]	Emberley ED, Mosadeghi R, Deshaies RJ . Deconjugation of Nedd8 from Cul1 is directly regulated by Skp1-F-box and substrate, and the COP9 signalosome inhibits deneddylated SCF by a noncatalytic mechanism. J Biol Chem, 2012,287(35):29679-29689.
[9]	Yu YS, Tang ZH, Pan QC, Chen XH, Liu XN, Zang GQ . Inhibition of CSN3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells. Cancer Chemoth Pharm, 2012,69(5):1173-1180.
[10]	Wang XM, Cui JW, Li W, Cai L, Song W, Wang GJ . Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis. Asian Pac J Cancer P, 2012,13(3):1043-1048.
[11]	Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MH . Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest, 2011,121(2):851-865.
[12]	Zhang XC, Chen J, Su CH, Yang HY, Lee MH . Roles for CSN5 in control of p53/MDM2 activities. J Cell Biochem, 2008,103(4):1219-1230.
[13]	Tomoda K, Kubota Y, Kato J . Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature, 1999,398(6723):160-165.
[14]	Yang X, Menon S, Lykke-Andersen K, Tsuge T, Di Xiao, Wang X, Rodriguez-Suarez RJ, Zhang H, Wei N . The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1. Curr Biol, 2002,12(8):667-672.
[15]	Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W . COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J, 2001,20(7):1630-1639.
[16]	Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG, Felici A, Lee DK, Kim SJ . Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol, 2004,24(6):2251-2262.
[17]	Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM . Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia, 2007,9(2):166-180.
[18]	Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM . Mining for regulatory programs in the cancer transcriptome. Nat Genet, 2005,37(6):579-583.
[19]	Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM . ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia, 2004,6(1):1-6.
[20]	Pollmann C, Huang X, Mall J, Bech-Otschir D, Naumann M, Dubiel W . The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells. Cancer Res, 2001,61(23):8416-8421.
[21]	Kob R, Kelm J, Posorski N, Baniahmad A, von Eggeling F, Melle C . Regulation of the anaphase-promoting complex by the COP9 signalosome. Cell Cycle, 2009,8(13):2041-2049.
[22]	Leal JF, Fominaya J, Cascón A, Guijarro MV, Blanco- Aparicio C, Lleonart M, Castro ME, Ramon Y, Cajal S, Robledo M, Beach DH, Carnero A . Cellular senescence bypass screen identifies new putative tumor suppressor genes. Oncogene, 2008,27(14):1961-1970.
[23]	Boutonnet C, Tanguay PL, Julien C, Rodier G, Coulombe P, Meloche S . Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2. Cell Cycle, 2010,9(5):975-979.
[24]	Bashir T, Pagan JK, Busino L, Pagano M . Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization. Cell Cycle, 2010,9(5):971-974.
[25]	Bhansali M, Shemshedini L . COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells. Mol Endocrinol, 2014,28(6):834-845.
[26]	Lingaraju GM, Bunker RD, Cavadini S, Hess D, Hassiepen U, Renatus M, Fischer ES, Thomä NH . Crystal structure of the human COP9 signalosome. Nature, 2014,512(7513):161-165.
[27]	Kollmann K, Heller G, Schneckenleithner C, Warsch W, Scheicher R, Ott RG, Schäfer M, Fajmann S, Schlederer M, Schiefer AI, Reichart U, Mayerhofer M, Hoeller C, Zöchbauer-Müller S, Kerjaschki D, Bock C, Kenner L, Hoefler G, Freissmuth M, Green AR, Moriggl R, Busslinger M, Malumbres M, Sexl V . A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell, 2016,30(2):359-360.
[28]	Thomas JW, Lee-Lin SQ, Green ED . Human-mouse comparative mapping of the genomic region containing CDK6: localization of an evolutionary breakpoint. Mamm Genome, 1999,10(7):764-767.
[29]	Schulze-Gahmen U, Kim SH . Structural basis for CDK6 activation by a virus-encoded cyclin. Nat Struct Biol, 2002,9(3):177-181.
[30]	Hetfeld BK, Peth A, Sun XM, Henklein P, Cohen GM, Dubiel W . The COP9 signalosome-mediated deneddylation is stimulated by caspases during apoptosis. Apoptosis, 2008,13(2):187-195.
[31]	Sang MM, Du WQ, Zhang RY, Zhang JN, Pei DS . Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways. Bioorg Med Chem Lett, 2015,25(15):2897-2901.
[32]	da Silva Correia J, Miranda Y, Leonard N, Ulevitch RJ . The subunit CSN6 of the COP9 signalosome is cleaved during apoptosis. J Biol Chem, 2007,282(17):12557-12565.
[33]	Lei D, Li F, Su H, Liu J, Wei N . Hepatic deficiency of COP9 signalosome subunit 8 induces ubiquitin-proteasome system impairment and Bim-mediated apoptosis in murine livers. PLoS One, 2013,8(7):e67793.
[34]	Dubois EL, Gerber S, Kisselev A, Harel-Bellan A, Groisman R . UV-dependent phosphorylation of COP9/ signalosome in UV-induced apoptosis. Oncol Rep, 2016,35(5):3101-3105.
[35]	Akiyama H, Fujisawa N, Tashiro Y, Takanabe N, Sugiyama A, Tashiro F . The role of transcriptional corepressor Nif3l1 in early stage of neural differentiation via cooperation with Trip15/CSN2. J Biol Chem, 2003,278(12):10752-10762.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

CSN4基因干扰对乳腺癌MDA-MB-231细胞增殖和凋亡的影响

Effects of CSN4 knockdown on proliferation and apoptosis of breast cancer MDA-MB-231 cells

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	禹奇超,宋彬,邹轩轩,王岭,刘德权,李波,马昆. 乳腺癌癌旁组织特异性表达基因分析[J]. 遗传, 2019, 41(7): 625-633.
[2]	姚传波, 周鑫, 陈策实, 雷群英. Hippo信号通路在乳腺癌中的调控机制及作用[J]. 遗传, 2017, 39(7): 617-629.
[3]	张潇飞,宋鹤,刘静,张文建,闫晓红,李辉,王宁. 鸡miR-17-92基因簇靶基因ZFPM2的鉴定及功能分析[J]. 遗传, 2017, 39(4): 333-345.
[4]	李泰明, 蓝文俊, 黄灿, 张春, 刘晓玫. 近红外荧光蛋白标记乳腺癌细胞外泌体的构建及鉴定[J]. 遗传, 2016, 38(5): 427-435.
[5]	赵建元,丁寄葳,米泽云,周金明,魏涛,岑山. HIV-1初始传播病毒Vpr基因遗传变异对诱导G₂期阻滞及细胞凋亡的影响[J]. 遗传, 2015, 37(5): 480-486.
[6]	毕丹,徐扬,逄越,李庆伟. 质膜组分磷脂酰丝氨酸外翻的分子调控机制[J]. 遗传, 2015, 37(2): 140-147.
[7]	张蕾, 隋御, 王婷, 李利坚, 李元杰, 金彩霞, 徐方. hMMS2基因对结肠癌细胞耐药逆转的影响[J]. 遗传, 2014, 36(4): 346-353.
[8]	常杨, 穆伟涛, 满朝来. 动物microRNA-181的功能与应用前景[J]. 遗传, 2014, 36(2): 103-110.
[9]	郭晓强，张巧霞，黄卫人，段相林，蔡志明. 染色质重塑因子ARID1A的肿瘤抑制作用[J]. 遗传, 2013, 35(3): 255-261.
[10]	王丽，那威，王宇祥，王彦博，王宁，王启贵，李玉茂，李辉. 鸡PPARγ基因的表达特性及其对脂肪细胞增殖分化的影响[J]. 遗传, 2012, 34(4): 454-464.
[11]	吴新刚，彭姝彬，黄谦. 乳腺癌耐药蛋白基因的转录调控机制[J]. 遗传, 2012, 34(12): 1529-1536.
[12]	程龙，黄翠芬，叶棋浓. 乳腺癌中雌激素受体α表达水平调节的分子机制[J]. 遗传, 2010, 32(3): 191-197.
[13]	王师尧，金巍娜，吴丹. 青少年型神经元蜡样脂褐质沉积病(JNCL)的发病机制[J]. 遗传, 2009, 31(8): 779-784.
[14]	马向东，马兴，吴小明，陈必良，王德堂 . 胚胎神经管缺陷大鼠模型差异基因的表达[J]. 遗传, 2009, 31(3): 280-284.
[15]	郭芬，刘兆宇，李月琴，李弘剑，周天鸿. Prosaposin对细胞增殖和凋亡的调控及其分子机制[J]. 遗传, 2009, 31(12): 1226-1232.